| From subjective cognitive decline to Alzheimer’s disease: The predictive role of neuropsychological assessment, personality traits, and cognitive reserve. A 7-year follow-up study V Bessi, S Mazzeo, S Padiglioni, C Piccini, B Nacmias, S Sorbi, L Bracco Journal of Alzheimer's Disease 63 (4), 1523-1535, 2018 | 91 | 2018 |
| The dual role of cognitive reserve in subjective cognitive decline and mild cognitive impairment: a 7-year follow-up study S Mazzeo, S Padiglioni, S Bagnoli, L Bracco, B Nacmias, S Sorbi, V Bessi Journal of neurology 266 (2), 487-497, 2019 | 63 | 2019 |
| Plasma neurofilament light chain as a biomarker of Alzheimer’s disease in Subjective Cognitive Decline and Mild Cognitive Impairment G Giacomucci, S Mazzeo, S Bagnoli, A Ingannato, D Leccese, V Berti, ... Journal of neurology 269 (8), 4270-4280, 2022 | 39 | 2022 |
| The implication of BDNF Val66Met polymorphism in progression from subjective cognitive decline to mild cognitive impairment and Alzheimer’s disease: a 9-year follow-up study V Bessi, S Mazzeo, S Bagnoli, S Padiglioni, M Carraro, I Piaceri, L Bracco, ... European Archives of Psychiatry and Clinical Neuroscience 270, 471-482, 2020 | 30 | 2020 |
| Combining cerebrospinal fluid biomarkers and neuropsychological assessment: a simple and cost-effective algorithm to predict the progression from mild cognitive impairment to … S Mazzeo, R Santangelo, MP Bernasconi, G Cecchetti, A Fiorino, P Pinto, ... Journal of Alzheimer's Disease 54 (4), 1495-1508, 2016 | 27 | 2016 |
| CHRNA7 gene and response to cholinesterase inhibitors in an Italian cohort of Alzheimer’s disease patients F Clarelli, E Mascia, R Santangelo, S Mazzeo, G Giacalone, D Galimberti, ... Journal of Alzheimer's Disease 52 (4), 1203-1208, 2016 | 19 | 2016 |
| Assessing the effectiveness of subjective cognitive decline plus criteria in predicting the progression to Alzheimer’s disease: An 11‐year follow‐up study S Mazzeo, S Padiglioni, S Bagnoli, M Carraro, I Piaceri, L Bracco, ... European Journal of Neurology 27 (5), 894-899, 2020 | 18 | 2020 |
| Influence of ApoE Genotype and Clock T3111C Interaction with Cardiovascular Risk Factors on the Progression to Alzheimer’s Disease in Subjective Cognitive … V Bessi, J Balestrini, S Bagnoli, S Mazzeo, G Giacomucci, S Padiglioni, ... Journal of Personalized Medicine 10 (2), 45, 2020 | 17 | 2020 |
| Gender differences in cognitive reserve: implication for subjective cognitive decline in women G Giacomucci, S Mazzeo, S Padiglioni, S Bagnoli, L Belloni, C Ferrari, ... Neurological Sciences, 1-10, 2022 | 16 | 2022 |
| Understanding factors associated with psychomotor subtypes of delirium in older inpatients with dementia A Morandi, A Zambon, SG Di Santo, A Mazzone, A Cherubini, E Mossello, ... Journal of the American Medical Directors Association 21 (4), 486-492. e7, 2020 | 14 | 2020 |
| Matching clinical diagnosis and amyloid biomarkers in alzheimer’s disease and frontotemporal dementia G Giacomucci, S Mazzeo, S Bagnoli, M Casini, S Padiglioni, C Polito, ... Journal of personalized medicine 11 (1), 47, 2021 | 12 | 2021 |
| KIBRA T allele influences memory performance and progression of cognitive decline: a 7-year follow-up study in subjective cognitive decline and mild cognitive … S Mazzeo, V Bessi, S Padiglioni, S Bagnoli, L Bracco, S Sorbi, B Nacmias Neurological Sciences 40, 1559-1566, 2019 | 12 | 2019 |
| Linguistic profiles, brain metabolic patterns and rates of amyloid-β biomarker positivity in patients with mixed primary progressive aphasia S Mazzeo, C Polito, S Padiglioni, V Berti, S Bagnoli, G Lombardi, I Piaceri, ... Neurobiology of Aging 96, 155-164, 2020 | 11 | 2020 |
| Acute symptomatic sinus bradycardia in high-dose methylprednisolone therapy in a woman with inflammatory myelitis: a case report and review of the literature A Sodero, M Squitieri, S Mazzeo, M Pasca, S Matà, F Pieri, V Bessi, ... Clinical Medicine Insights: Case Reports 12, 1179547619831026, 2019 | 11 | 2019 |
| Degradation of EEG microstates patterns in subjective cognitive decline and mild cognitive impairment: Early biomarkers along the Alzheimer’s Disease continuum? M Lassi, C Fabbiani, S Mazzeo, R Burali, AA Vergani, G Giacomucci, ... NeuroImage: Clinical 38, 103407, 2023 | 10 | 2023 |
| The effect of CAG repeats within the non-pathological range in the HTT gene on cognitive functions in patients with subjective cognitive decline and mild cognitive impairment V Bessi, S Mazzeo, S Bagnoli, G Giacomucci, A Ingannato, C Ferrari, ... Diagnostics 11 (6), 1051, 2021 | 8 | 2021 |
| PER2 C111G polymorphism, cognitive reserve and cognition in subjective cognitive decline and mild cognitive impairment: a 10‐year follow‐up study V Bessi, G Giacomucci, S Mazzeo, S Bagnoli, S Padiglioni, J Balestrini, ... European Journal of Neurology 28 (1), 56-65, 2021 | 8 | 2021 |
| Loss of speech and functional impairment in Alzheimer's disease-related primary progressive aphasia: predictive factors of decline S Mazzeo, C Polito, M Lassi, S Bagnoli, M Mattei, S Padiglioni, V Berti, ... Neurobiology of Aging 117, 59-70, 2022 | 7 | 2022 |
| Unravelling neural correlates of empathy deficits in subjective cognitive decline, mild cognitive impairment and Alzheimer’s disease G Giacomucci, G Galdo, C Polito, V Berti, S Padiglioni, S Mazzeo, ... Behavioural Brain Research 428, 113893, 2022 | 7 | 2022 |
| PRedicting the EVolution of SubjectIvE Cognitive Decline to Alzheimer’s Disease With machine learning: the PREVIEW study protocol S Mazzeo, M Lassi, S Padiglioni, AA Vergani, V Moschini, M Scarpino, ... BMC neurology 23 (1), 300, 2023 | 6 | 2023 |
